USPTO serial 90696150
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
First Gain International Limited
Hong Kong, HK
First Gain International Limited
Hong Kong, HK
First Gain International Limited
Hong Kong, HK
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Timothy T. Wang
Timothy T. Wang NI, WANG & MASSAND, PLLC8140 WALNUT HILL LANE, SUITE 500DALLAS, TX 75231UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Human and veterinary pharmaceutical preparations for the prevention and treatment of cardiovascular disorders, tissue hypoxia, shock and anemia; Human and veterinary pharmaceutical preparations to increase plasma oxygen content; Biological preparations for medical and veterinary purposes, namely, Sterile Solutions for use in Oxygen therapeutics for the treatment of cardiovascular disorders, tissue hypoxia, shock, anemia, Gastrointestinal and Hepatobiliary System disease, Cardiovascular and Hematopoietic System diseases, Respiratory System diseases, Central Nervous System diseases, Musculo-Skeletal System diseases, Hormones related diseases, Oncology diseases, Genito-Urinary System diseases, Endocrine and Metabolic System diseases, Eye diseases, Ear and Mouth or Throat diseases, Skin diseases, Allergy and Immune System diseases; biological preparations for medical and veterinary purposes, namely, hemoglobin solution for pharmaceutical purpose and intravenous infusion solutions of a synthetic colloids and crystalloids all for the treatment of cardiovascular disorders, tissue hypoxia, shock, anemia, Gastrointestinal and Hepatobiliary System disease, Cardiovascular and Hematopoietic System diseases, Respiratory System diseases, Central Nervous System diseases, Musculo-Skeletal System diseases, Hormones related diseases, Oncology diseases, Genito-Urinary System diseases, Endocrine and Metabolic System diseases, Eye diseases, Ear and Mouth or Throat diseases, Skin diseases, Allergy and Immune System diseases; Biological preparations for medical and veterinary purposes, namely, protein arrays, biological tissue cultures, blood, blood plasma, and blood serums for the treatment of cardiovascular disorders, tissue hypoxia, shock, anemia, Gastrointestinal and Hepatobiliary System disease, Cardiovascular and Hematopoietic System diseases, Respiratory System diseases, Central Nervous System diseases, Musculo-Skeletal System diseases, Hormones related diseases, Oncology diseases, Genito-Urinary System diseases, Endocrine and Metabolic System diseases, Eye diseases, Ear and Mouth or Throat diseases, Skin diseases, Allergy and Immune System diseases | ACTIVE | — |
| 044 | Medical services, namely, healthcare services in the nature of medical information, hospital services, medical assistance services, medical clinic services, and therapy services, physical therapy; Veterinary services in the nature of veterinary information; Hygienic and beauty care for human beings or animals | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 23, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 23, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 7, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 7, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 18, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 3, 2022 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Apr 29, 2022 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Apr 26, 2022 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Apr 22, 2022 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Apr 20, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 19, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 19, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 19, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 12, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 12, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 12, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 12, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 10, 2021 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 9, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 11, 2021 | NWAP | NEW APPLICATION ENTERED | — |